Model-based evaluation of the cost effectiveness of 3 versus 6 monthsâ adjuvant chemotherapy in high-risk stage II colon cancer patients
Jongeneel, Gabrielle, Greuter, Marjolein J. E., van Erning, Felice N., Koopman, Miriam, Vink, Geraldine R., Punt, Cornelis J. A., Coupé, Veerle M. H.Volume:
13
Journal:
Therapeutic Advances in Gastroenterology
DOI:
10.1177/1756284820954114
Date:
January, 2020
File:
PDF, 594 KB
2020